63931-22-6 Usage
Description
5-Bromo-6-chloro-2-(methylthio)-4-pyrimidinamine is a pyrimidine derivative chemical compound with the molecular formula C6H5BrN3ClS. It contains bromine, chlorine, nitrogen, and sulfur atoms, making it a versatile molecule for various applications.
Uses
Used in Pharmaceutical Industry:
5-Bromo-6-chloro-2-(methylthio)-4-pyrimidinamine is used as an intermediate in the synthesis of pharmaceuticals for its potential therapeutic properties.
Used in Agricultural Chemicals:
5-Bromo-6-chloro-2-(methylthio)-4-pyrimidinamine also serves as an intermediate in the synthesis of agricultural chemicals, contributing to the development of new products for crop protection and enhancement.
Used in Chemical Research and Development:
5-Bromo-6-chloro-2-(methylthio)-4-pyrimidinamine is utilized in the field of chemical research and development, where its unique structure and properties are explored for new applications and advancements in chemical science.
Safety Note:
It is crucial to handle 5-Bromo-6-chloro-2-(methylthio)-4-pyrimidinamine with caution due to its potential hazardous effects if not managed properly. Proper safety measures should be taken during its use in any application.
Check Digit Verification of cas no
The CAS Registry Mumber 63931-22-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,9,3 and 1 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 63931-22:
(7*6)+(6*3)+(5*9)+(4*3)+(3*1)+(2*2)+(1*2)=126
126 % 10 = 6
So 63931-22-6 is a valid CAS Registry Number.
63931-22-6Relevant articles and documents
1-(4-AMINO-5-BROMO-6-(1 H-PYRAZOL-1-YL)PYRIMIDIN-2-YL)-1 H-PYRAZOL-4-OL AND USE THEREOF IN THE TREATMENT OF CANCER
-
Page/Page column 51; 52, (2018/09/08)
This invention relates to an active metabolite of 5-bromo-2,6-di(1H-pyrazol-1-yl)pyrimindin-4-amine that modulates the activity of adenosine A2a receptor. In particular, the present invention relates to pharmaceutical compositions comprising 1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)-pyrimidin-2-yl)-1H-pyrazol-4-ol, as well as processes for its preparation and its use in the treatment of cancer alone of in combination with one or more immunotherapeutic agents.